Last Update Time:
18-Mar-2025 16:00:00
ISIN:
INE752H01013
Sector:
Financial Services
Symbol:
CARERATING
CARE Ratings Limited
₹1,098.00
₹22.85
(2.13%)
▲
Prev. Close
₹1,075.15
Open
₹1,077.00
Close
₹1,096.60
Range
₹1,043.10 - ₹1,152.90
High
₹1,114.00
Low
₹1,077.00
Ind. Close
₹0.00
VWAP
₹1,101.00
The current stock price of CARE Ratings Limited is ₹1,098.00, with a target price range between ₹1,043.10 and ₹1,152.90. The stock has experienced a price change of ₹22.85 (2.13%), reflecting recent market volatility.
Today's opening price was ₹1,077.00, while the previous close stood at ₹1,075.15.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
CARE Ratings Limited Price Chart
CARE Ratings Limited Pre Open Market Overview: 18-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 1077
- Previous Close Price: 1075.15
- Change: 1.85%
- Total Traded Volume: 52
- Total Buy Quantity: 547
- Total Sell Quantity: 1,099
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 1,062.20 | 1.00 | 0.00 |
| 1,070.05 | 1.00 | 0.00 |
| 1,075.15 | 11.00 | 0.00 |
| 1,075.25 | 27.00 | 0.00 |
| 1,077.00 | 10.00 | 0.00 |
| 1,091.25 | 0.00 | 4.00 |
| 1,094.00 | 0.00 | 15.00 |
| 1,100.00 | 0.00 | 2.00 |
| 1,108.40 | 0.00 | 50.00 |
| 1,115.00 | 0.00 | 4.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 547
Total Sell Quantity: 1099
Shareholding Patterns of CARE Ratings Limited
Key Trade Statistics of CARE Ratings Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 0.32 |
| Traded Value (₹ Cr.) | 3.49 |
| Total Market Cap (₹ Cr.) | 3,285.09 |
| Free Float Market Cap (₹ Cr.) | 2,992.19 |
| Impact cost | 0.15 |
| Quantity Traded | 31,735.00 |
| Deliverable Quantity | 17,904.00 |
| % of Quantity to Traded | 56.42 |
| Security VaR | 16.73 |
| Index VaR | N/A |
| VaR Margin | 16.73 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 20.23 |
| Face Value | 10 |
Key Price Statistics of CARE Ratings Limited
The 52-week high for CARE Ratings Limited was ₹1,571.00, recorded on 07-Nov-2024. On the other hand, the 52-week low stands at ₹921.80, with the lowest value recorded on 07-Aug-2024.
The upper band for trading is ₹1,290.15, and the lower band is ₹860.15. The price band is 20%.
The stock's daily volatility stands at 2.58, while the annualized volatility is 49.29. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (07-Nov-2024) | 1,571.00 |
| 52 Week Low (07-Aug-2024) | 921.80 |
| Upper Band | 1,290.15 |
| Lower Band | 860.15 |
| Price Band (%) | 20 |
| Daily Volatility | 2.58 |
| Annualised Volatility | 49.29 |
| Tick Size | 0.05 |
Key Securities Statistics of CARE Ratings Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 26-Dec-2012 |
| Adjusted P/E | 26.54 |
| Symbol P/E | 26.54 |
| Index | NA |
| Macro-Economic Sector | Financial Services |
| Sector | Financial Services |
| Industry | Capital Markets |
| Basic Industry | Ratings |
Security Status of CARE Ratings Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of CARE Ratings Limited
| Subject | Date |
|---|---|
| Alteration Of Capital and Fund Raising-XBRL | 11-Mar-2025 |
| ESOP/ESOS/ESPS | 11-Mar-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 24-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 18-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 18-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 14-Feb-2025 |
| Alteration Of Capital and Fund Raising-XBRL | 13-Feb-2025 |
| ESOP/ESOS/ESPS | 13-Feb-2025 |
Corporate Actions of CARE Ratings Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 10 | Interim Dividend - Rs 7 Per Share | 05-Nov-2024 |
| 10 | Dividend - Rs 11 Per Share | 21-Jun-2024 |
| 10 | Interim Dividend - Rs 7 Per Share | 10-Nov-2023 |
| 10 | Dividend - Rs 7 Per Share /Special Dividend - Rs 8 Per Share | 07-Jul-2023 |
| 10 | Interim Dividend - Rs 10 Per Share | 10-Feb-2023 |
| 10 | Dividend - Rs 10 Per Share | 13-Sep-2022 |
| 10 | Buy Back | 13-Sep-2022 |
| 10 | Interim Dividend - Rs 7 Per Share | 11-Nov-2021 |
| 10 | Annual General Meeting/Dividend - Rs 6 Per Share | 06-Sep-2021 |
| 10 | Interim Dividend - Rs 3 Per Share | 17-Feb-2021 |
| 10 | Interim Dividend - Rs 8 Per Share | 18-Nov-2020 |
| 10 | Annual General Meeting/Dividend - Rs 2.50 Per Share | 31-Aug-2020 |
| 10 | Interim Dividend - Rs 6 Per Share | 20-Feb-2020 |
| 10 | Interim Dividend - Rs 8 Per Share | 19-Nov-2019 |
| 10 | Annual General Meeting/Dividend - Rs 12 Per Share | 19-Sep-2019 |
| 10 | Interim Dividend - Rs 3 Per Share | 19-Aug-2019 |
| 10 | Interim Dividend - Rs 6 Per Share | 21-Feb-2019 |
| 10 | Interim Dividend - Rs 6 Per Share | 15-Nov-2018 |
| 10 | Annual General Meeting/ Final Dividend-Rs 12 Per Share/ Special Dividend- Rs 25 Per Share | 18-Sep-2018 |
| 10 | Interim Dividend- Rs 6.00 Per Share | 24-Aug-2018 |
Board Meetings of CARE Ratings Limited
Financial Results of CARE Ratings Limited
Company Directory of CARE Ratings Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| www.careratings.com | Registered Office | 4th Floor, Godrej Coliseum, Somaiya, Hospital Road, Off Eastern Express, Highway, Sion (East), | MUMBAI |
| www.careratings.com | Transfer Agent | Karvy Computershare Private Limited Karvy Selenium Tower - B, Plot No. 31 & 32, Financial District, Nanakramguda, Gachibowli, Hyderabad - 500032 Talangana | HYDERABAD |
Insider Trading of CARE Ratings Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | Priti Agarwal | 368637 | Sell |
| 7(2) | Priti Agarwal | 1109472 | Buy |
| 7(2) | Priti Agarwal | 368637 | Sell |
| 7(2) | Priti Agarwal | 1109472 | Buy |
| 7(2) | AJAY MAHAJAN | 56666780 | Buy |
| 7(2) | CANARA BANK | 4305120360 | Sell |
| 7(2) | Divyesh Shah | 1200000 | Sell |
| 7(2) | Priti Agarwal | 492000 | Sell |
| 7(2) | P. Sandeep | 3230030 | Sell |
| 7(2) | P. Sudhakar | 1471500 | Sell |
| 7(2) | Milind Raje | 1623053 | Sell |
| 7(2) | Priti Agarwal | 1607659 | Sell |
| 7(2) | Priti Agarwal | 3939678 | Sell |
| 7(2) | Priti Agarwal | 2960940 | Sell |
| 7(2) | YOGESH SHAH | 2782556 | Sell |
| 7(2) | Milind A. Gadkari | 2207015 | Sell |
| 7(2) | Milind A. Gadkari | 733000 | Sell |
| 7(2) | CANARA BANK | 1300168.4 | Sell |
| 7(2) | CANARA BANK | 3838941.75 | Sell |
| 7(2) | CANARA BANK | 3880503 | Sell |
Annual Reports of CARE Ratings Limited
Investor Complaints of CARE Ratings Limited
Event Calendar of CARE Ratings Limited
| Purpose | Details |
|---|---|
| Dividend | inter alia, to consider the declaration of Interim Dividend, if any, for the financial year 2012-13. |
| Results/Dividend | To consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2013 and to recommend dividend, if any, on the equity shares of the Company for the financial Year 2012-13. |
| Board meeting Rescheduled | The Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on May 06, 2013 to consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2013 and to recommend dividend, if any, on the equity shares of the Company for the financial Year 2012-13. The Company has now informed the Exchange that the aforesaid Board Meeting has been re-scheduled to be held on May 15, 2013 instead of May 06, 2013. |
| Results/Dividend | The company had informed the Exchange that the meeting of the Board of Directors of the Company is scheduled to be held on August 10, 2013 inter-alia, to consider the Unaudited Financial Results for the first quarter of FY 2013-14 ended June 30, 2013. The company has now informed the Exchange that, in the aforesaid meeting, the declaration of interim dividend, if any for the financial year 2013-14 will also be considered. (Purpose Revised). |
| Results | Inter-alia, to consider the Unaudited Financial Results for the first quarter of FY 2013-14 ended June 30, 2013. |
| Results | Inter-alia, to consider the Unaudited Financial Results for the second quarter and half year of FY 2013-14 ended September 30, 2013. |
| Results/Dividend | The Company had informed the Exchange regarding a Board Meeting to be held on January 19, 2014 inter-alia, to consider the Unaudited Financial Results for the third quarter and nine months ended December 31, 2013. The Company has now informed that in the same meeting to be held on January 19, 2014, the declaration of interim dividend, if any for the financial year 2013-14 will also be considered. (Purpose Revised) |
| Results | inter-alia, to consider the Unaudited Financial Results for the third quarter and nine months ended December 31, 2013. |
| Results/Dividend | To consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2014 and to recommend dividend, if any, on the equity shares of the Company for the financial Year 2013-14. |
| Results/Dividend | Inter alia, to consider the Unaudited Financial Results for the quarter ended June 30, 2014 and the declaration of Interim Dividend, if any for the financial year 2014-15. |
| Dividend | Inter-alia to consider the declaration of Special Dividend (Interim - 2), for the financial year 2014-15. |
| Results/Dividend | Inter-alia, to consider the unaudited Financial Results for the quarter and half year ended September 30, 2014 and the declaration of Interim Dividend, if any for the financial year 2014-15. |
| Results/Dividend | Inter-alia, to consider the Unaudited Financial Results for the quarter and nine months ended December 31, 2014 and the declaration of Interim Dividend, if any for the financial year 2014-15. |
| Results/Dividend | Inter-alia, to consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2015 and to recommend Dividend, if any, on the equity shares of the Company for the financial year 2014-15. |
| Results/Dividend | Inter alia, to consider the Unaudited Financial Results for the quarter ended June 30, 2015 and the declaration of Interim Dividend, if any for the financial year 2015-16. |
| Results/Dividend | Inter-alia, to consider the Unaudited Financial Results for the quarter and half year ended September 30, 2015 and the declaration of Interim Dividend, if any for the financial year 2015-16. |
| Results/Dividend | Inter-alia, to consider the Unaudited Financial Results for the quarter and nine months ended December 31, 2015 and the declaration of Interim Dividend, if any for the financial year 2015-16. |
| Results/Dividend | inter-alia, to consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2016 and to recommend Dividend, if any, on the equity shares of the Company for the financial year 2015-16. |
| Results/Dividend | Inter-alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2016 and the declaration of Interim Dividend, if any for the financial year 2016-17. |
| Results/Dividend | Inter-alia, to consider and approve the Unaudited Financial Results for the quarter and half year ended September 30, 2016 and the declaration of Interim Dividend, if any for the financial year 2016-17. |
| Results/Dividend | Inter-alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2016 and the declaration of Interim Dividend, if any for the financial year 2016-17. |
| Results/Dividend | inter-alia, to consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2017 and to recommend Dividend, if any on the equity shares of the Company for the financial year 2016-17. |
| Board meeting Rescheduled | CARERATING : 22-Aug-2017 : The Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held August 23, 2017, inter alia to consider and approve the Unaudited Financial results of the Company for the quarter ended June 30, 2017 and the declaration of Interim Dividend, if any for the financial year 2017-18. The Company has now informed the Exchange that the Board meeting has been preponed and it is now proposed to hold the Board Meeting on August 22, 2017, inter-alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2017 and the declaration of Interim Dividend, if any for the financial year 2017-18. |
| Results/Dividend | in Mumbai inter-alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2017 and the declaration of Interim Dividend, if any for the financial year 2017-18. |
| Results/Dividend | inter alia to consider and approve the Unaudited Financial results of the Company for the quarter ended June 30, 2017 and the declaration of Interim Dividend, if any for the financial year 2017-18. |
| Results/Dividend | Inter-alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2017 and the declaration of Interim Dividend, if any for the financial year 2017-18. |
| Results/Dividend | inter-alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2017 and the declaration of Interim Dividend, if any for the financial year 2017-18. |
| Results/Dividend | Inter-alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2017 and the declaration Interim Dividend, if any for the financial year 2017-18. |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2018 and dividend |
| Financial Results/Dividend | This is to inform you that pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of CARE Ratings Limited, will be held on Monday, August 13, 2018 at the registered office of the company, Mumbai, inter-alia (a) to consider and take on record the Unaudited Financial Results of the Company for the quarter ended June 30, 2018. (b) to consider declaration of 1st Interim Dividend, if any for the financial year 2018-19.Further to our intimation to the Stock Exchange vide our letter dated July 12, 2018 for closure of trading window, we would like to inform you that the trading window for dealing in the securities of CARE which was closed on July 13, 2018 will be opened on August 17, 2018 for dealing in the shares of CARE as per the provisions of SEBI (Prohibition of Insider Trading Regulations), 2015. |
| Financial Results/Dividend | To consider and approve the financial results for the period ended September 30, 2018 and dividend.This is to inform you that pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of CARE Ratings Limited, will be held on Friday, November 02, 2018 at the registered office of the company, Mumbai, inter-alia (a) to consider and take on record the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2018. (b) to consider declaration of 2nd Interim Dividend, if any for the financial year 2018-19.ￂﾠFurther to our intimation to the Stock Exchange vide our letter dated October 04, 2018 for closure of trading window, we would like to inform you that the trading window for dealing in the securities of CARE which was closed on October 05, 2018 will be opened on Tuesday, November 06, 2018 for dealing in the shares of CARE as per the provisions of SEBI (Prohibition of Insider Trading Regulations), 2015. |
| Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2018 and dividendThis is to inform you that pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of CARE Ratings Limited, will be held on Monday, February 11, 2019 at the registered office of the company, Mumbai, inter-alia (a) to consider and take on record the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2018. (b) To consider declaration of 3rd Interim Dividend, if any for the financial year 2018-19.Further to our intimation to the Stock Exchange vide our letter dated December 31, 2018 for closure of trading window, we would like to inform you that the trading window for dealing in the securities of CARE which was closed on January 01, 2019 will be opened on Thursday, February 14, 2019 for dealing in the shares of CARE as per the provisions of SEBI (Prohibition of Insider Trading Regulations), 2015. |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2019 and dividendThis is to inform you that pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of CARE Ratings Limited, will be held on Tuesday, May 21, 2019 at the registered office of the company, Mumbai, inter-alia, (a) To consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2019. (b). To recommend Dividend, if any for the financial year 2018-19.Further to our intimation to the Stock Exchange vide our letter dated April 01, 2019 for closure of trading window, we would like to inform you that the trading window for dealing in the securities of CARE which was closed on April 01, 2019 will be opened on May 24, 2019 for dealing in the shares of CARE as per the provisions of SEBI (Prohibition of Insider Trading Regulations), 2015. |
| Financial Results/Dividend | To consider and approve the financial results for the period ended Jun 30, 2019 and dividend, if any. |
| Financial Results/Dividend | To consider and approve the financial results for the period ended September 30, 2019 and dividend, if any. |
| Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2019 and dividend |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2020 and dividend |
| Financial Results/Dividend | To consider and approve the audited financial results for the period ended March 31, 2020 and dividend if any |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2020 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended September 30, 2020 and dividend |
| Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2020 and dividend, if any |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2021 |
| Financial Results | To consider and approve the Unaudited (Standalone & Consolidated ) Financial Results of the Company for the quarter ended June 30, 2021 |
| Financial Results/Dividend | (a)(a) consider and approve the Unaudited (Standalone & Consolidated) Financial Results of the Company for the quarter and half year ended September 30, 2021; and (b)consider declaration of interim dividend, if any. |
| Financial Results/Dividend | To consider and approve the Unaudited (Standalone & Consolidated) Financial Results of the Company for the the quarter and nine months ended December 31, 2021 and dividend, if any. |
| Buyback | CARE Ratings Limited has informed the Exchange about Board Meeting to be held on 20-Jul-2022 to consider Buyback |
| Financial results | CARE Ratings Limited has informed the Exchange about Board Meeting to be held on 29-Jul-2022 to consider financial statements for the period ended June 2022 |
| Financial results | CARE Ratings Limited has informed the Exchange about Board Meeting to be held on 08-Nov-2022 to consider financial statements for the period ended September 2022 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2022 and dividend, if any. |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2023 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended September 30, 2023 and dividend |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2023 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2024 and to recommend dividend, if any. |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended September 30, 2024 and interim dividend |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
Share Transfers of CARE Ratings Limited
Voting Results of CARE Ratings Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 09-JUL-2024 | AGM | To receive, consider and adopt the Audited Financial Statement (including the Consolidated Financial Statement) for the financial year ended March 31, 2024 together with the Reports of the Board of Directors and the Auditors thereon. |
| 09-JUL-2024 | AGM | Appointment of Mr. Manoj Chugh (DIN: 02640995) as a Non-Executive Independent Director of the Company |
| 09-JUL-2024 | AGM | To appoint a director in place of Mr. Sobhag Mal Jain (DIN: 08770020), who retires by rotation and being eligible, offers himself for re-appointment |
| 09-JUL-2024 | AGM | To confirm the payment of interim dividend of Rs.7/- (Rupees Seven only) per equity share of face value of Rs. 10/- (Rupees Ten only) and to declare a final dividend of Rs.11/- (Rupees Eleven only) per equity share of face value of Rs. 10.00/- (Rupees Ten only) for the financial year 2023-24 |
| 28-JUL-2023 | AGM | Adoption of the audited financial statements standalone (including the Consolidated Financial Statement) for the financial year ended March 31, 2023 together with the reports of Board of Directors and the Auditors thereon. |
| 28-JUL-2023 | AGM | Re-appointment of Mr. Mehul Pandya (DIN: 07610232), as Director liable to retire by rotation. |
| 28-JUL-2023 | AGM | To confirm the payment of interim dividend of Rs.10/- (Rupees Ten Only) per equity share and declaration of final dividend of Rs.7/- (Rupees Seven Only) per and a special dividend of Rs.8/- (Rupees Eight only) per equity share for the financial year 2022-23. |
| 15-APR-2023 | Postal Ballot | Appointment of Mr. Sobhag Mal Jain (DIN-08770020) as a Non-Executive Non-Independent Director of the Company |
| 21-JAN-2023 | Postal Ballot | Approval for payment of remuneration by way of commission to Non-Executive Directors including Independent Directors of the Company |
| 21-JAN-2023 | Postal Ballot | Approval of Re-designation of Mr. V. Chandrasekaran (DIN: 03126243) as a Non-Executive Independent Director of the Company |
| 21-JAN-2023 | Postal Ballot | Approval of Appointment of Mr. G. Mahalingam (DIN: 09660723) as a Non-Executive Independent Director of the Company |
| 21-JAN-2023 | Postal Ballot | Approval of Grant of employee stock options under the CARE Employee Stock Option Scheme 2020 to employees of subsidiary companies, group companies, holding companies and associate companies as applicable |
| 21-JAN-2023 | Postal Ballot | Approval of Amendments to CARE Employee Stock Option Scheme 2020 |
| 26-SEP-2022 | AGM | Adoption of the audited standalone & consolidated financial statements for the financial year ended March 31, 2022 together with the reports of Board of Directors and the Auditors thereon. |
| 26-SEP-2022 | AGM | Appointment of Mr. Mehul Pandya (DIN: 07610232) as Director liable to retire by rotation |
| 26-SEP-2022 | AGM | Re-appointment of Dr. M. Mathisekaran (DIN: 03584338) as an Independent Director of the Company for a second term |
| 26-SEP-2022 | AGM | Re-appointment of Ms. Sonal Gunvant Desai (DIN: 08095343) as an Independent Director of the Company for a second term |
| 26-SEP-2022 | AGM | Re-appointment of Mr. Najib Shah (DIN: 08120210) as an Independent Director of the Company for a second term |
| 26-SEP-2022 | AGM | Re-appointment of Mr. V. Chandrasekaran (DIN: 03126243) as Director liable to retire by rotation. |
| 26-SEP-2022 | AGM | To confirm the payment of interim dividend of Rs. 7/- (Rupees Seven Only) per equity share and declaration of final dividend of Rs. 10/- (Rupees Ten Only) per equity share for the financial year 2021-22 |
FAQs on CARE Ratings Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.